Related Experiment Video
Updated: Jun 28, 2025
11:29
miRNA Expression Analyses in Prostate Cancer Clinical Tissues
Published on: September 8, 2015
10.9K
lncRNA RMST is associated with the progression and prognosis of gastric cancer via miR-204-5p
Huimei Cai1, Chenhui Li2, Zhou Wu3
1Department of Gastroenterology, Affiliated Fuzhou First Hospital of Fujian Medical University, No. 190, Dadao Road, Taijiang District, Fuzhou, 350000, China. caihuimeidr@163.com.
Cell Division
|April 12, 2024
Summary
Long non-coding RNA RMST promotes gastric cancer by regulating miR-204-5p. Inhibiting RMST offers a potential therapeutic strategy for gastric cancer patients, improving prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Biomarker Discovery
Background:
- Gastric cancer necessitates novel biomarkers for improved patient outcomes.
- Long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) are implicated in various cancers.
- The specific role and mechanism of lncRNA RMST in gastric cancer remain largely unexplored.
Purpose of the Study:
- To investigate the role of lncRNA RMST in gastric cancer development.
- To elucidate the underlying molecular mechanism of RMST in gastric cancer.
- To evaluate RMST as a potential prognostic biomarker and therapeutic target.
Main Methods:
- Quantitative real-time PCR to assess RMST expression in gastric cancer tissues.
- Correlation analysis to link RMST levels with clinical parameters (lymph node metastasis, TNM stage).
- In vitro experiments to study the regulatory relationship between RMST and miR-204-5p, and their effects on cell growth and metastasis.
Main Results:
- RMST was significantly upregulated in gastric cancer tissues compared to normal tissues.
- Elevated RMST levels correlated with advanced TNM stage and lymph node metastasis, predicting poor prognosis.
- RMST negatively regulated miR-204-5p; this interaction mediated RMST's promotion of gastric cancer cell growth and metastasis.
Conclusions:
- RMST functions as a tumor promoter and prognostic biomarker in gastric cancer by modulating miR-204-5p.
- Targeting RMST presents a promising therapeutic strategy for gastric cancer treatment.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K